Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $40.3 million.

  • Organogenesis Holdings' Accumulated Expenses rose 1165.9% to $40.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.3 million, marking a year-over-year increase of 1165.9%. This contributed to the annual value of $39.5 million for FY2024, which is 3118.64% up from last year.
  • Organogenesis Holdings' Accumulated Expenses amounted to $40.3 million in Q3 2025, which was up 1165.9% from $26.3 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Accumulated Expenses high stood at $40.3 million for Q3 2025, and its period low was $25.4 million during Q1 2021.
  • Over the past 5 years, Organogenesis Holdings' median Accumulated Expenses value was $34.2 million (recorded in 2022), while the average stood at $33.2 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 5554.58% in 2021, then tumbled by 3069.23% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Accumulated Expenses (Quarter) stood at $37.3 million in 2021, then decreased by 29.08% to $26.4 million in 2022, then grew by 13.71% to $30.1 million in 2023, then soared by 31.19% to $39.5 million in 2024, then increased by 2.17% to $40.3 million in 2025.
  • Its Accumulated Expenses was $40.3 million in Q3 2025, compared to $26.3 million in Q2 2025 and $31.1 million in Q1 2025.